|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
 |
Case ID: 4369 | Drugs / Medical | 08/02/2005
Ten women filed a lawsuit seeking class action status against patch manufacturer Johnson & Johnson and its subsidiary Ortho McNeil on July 25, 2005. The lawsuit claims the birth control device caused them to suffer strokes and blood clots.
The lawsuit, filed in Hudson County, N.J. Superior Court alleges that the popular Ortho Evra birth control patch is "defectively designed" and "unreasonably dangerous." The suit seeks punitive damages against pharmaceutical giant Johnson & Johnson (Research) and its subsidiary, Ortho McNeil, the patch's manufacturer. One of the Austin, Texas-based plaintiffs' attorney handling the case said the clients listed in the suit include women ranging from 18 to 47 from Arizona, Arkansas, California, Colorado, Connecticut, Maryland, Mississippi, New Jersey, Ohio and Oklahoma. All have suffered debilitating long-term health problems, they claim, as a result of using the birth control patch. Register your Johnson Johnson Ortho Mcneil ComplaintIf you or someone you know has been affected by this case, you may qualify for a money settlement as the result of your financial/economic or other damages that may be awarded either prior to a lawsuit or after the initiation of a lawsuit either currently in progress or filed just for you, possibly a class action lawsuit. Please simply register your complaint by clicking here for Johnson Johnson Ortho Mcneil, or click the red "submit" button on this page, and a lawyer will review your Johnson Johnson Ortho Mcneil complaint. By submitting your complaint, you are asking lawyers to contact you. You are under no obligation to accept their services and you are free to choose which lawyer you want to work with. Lawyers are usually paid out of the proceeds of the settlement or verdict rendered - the lawyers work on "contingency" by fronting the costs of your lawsuit based on their belief that they will recover a settlement for you. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Drugs / Medical Cases of Interest Patients aren’t the only ones that have been hurt by the HMO phenomenon. A class of physicians has been certified in an action filed against some of the nation's largest managed care companies. The doctors charge that the plans conspired to breach contracts and defraud them in violation of the federal Racketeer Influenced and Corrupt Organizations Act (RICO). Kahn Gauthier Swick is investigating possible legal actions against Cordis Corporation on behalf of persons who have been injured by the company's Cypher coronary stent. On October 29, 2003, the federal Food and Drug Administration issued a warning that a significant number of adverse effects had been reported since the Cypher stent was approved on April 24. Both blood clotting and hypersensitivity reactions have been reported. A class action has been filed against non-invasive surgical treatments provider HealthTronics Surgical Services, Inc. (Nasdaq: HTRN) and certain of its officers and directors by stockholders who purchased the company's common stock between January 4, 2000, and July 25, 2003. A class action lawsuit has been filed in the Southern District of New York against Lenox Hill Hospital. The case involves violations of the Employee Retirement Income Security Act (ERISA). No additional information about the substance of the allegations is available at this time. Classactionamerica.com will monitor this case and provide additional details as soon as they become available. Several class actions have been filed against prosthetics company Hanger Orthopedic Group, Inc., (NYSE: HGR) and certain of its officers and directors by stockholders who purchased the company's common stock between July 29, 2003, and June 14, 2004. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities.
A class action lawsuit has been filed in federal court against pharmaceutical giant Novartis Corporation. The cover sheet filed with the complaint indicates that the case alleges discrimination in employment, and seeks damages of one hundred million dollars. The full text of the complaint is not yet accessible and no additional information about the substance of the allegations is available at this time. Classactionamerica.com will monitor this case and provide additional details as soon as they become available. |
IT'S FREE
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
